BIOMARIN PHARMACEUTICAL INC
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
BMRN$57.18+2.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
The following table contains information about our significant owned and leased properties as of December 31, 2025:
| Location | ApproximateSquare Feet | Use | LeaseExpirationDate |
|---|---|---|---|
| San Rafael facility, San Rafael, California | 407,200 | Corporate headquarters, laboratory and office | Owned property |
| Several facilities in Novato, California | 292,300 | Clinical and commercial manufacturing, laboratory and office | Owned property |
| Several leased facilities in Novato, California | 149,500 | Office and warehouse | 2027 |
| Shanbally facility, Cork, Ireland | 260,700 | Manufacturing, laboratory and office | Owned property |
We expect that these properties, together with our other smaller leased office facilities in various countries, will be adequate for our operations for the foreseeable future.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.